Yuhan Pregabalin Extended-Release Tablets 150 mg (Pregabalin)

Adult dosage

This medication is administered once daily after the evening meal. It should be swallowed whole and must not be divided, crushed, or chewed. The starting dose may be 150 mg once daily. Based on individual patient responses and tolerability, the dose can be increased weekly to a maximum of 600 mg per day.

Children's dosage

Safety and efficacy have not been established in patients under 19 years of age.

This medication may increase the risk of suicidal thoughts or behaviors, so if symptoms of depression or mood changes occur during treatment, you should consult a healthcare professional immediately. Do not take this medication if you are allergic to any of its ingredients. Diabetic patients should be careful as weight gain may require adjustment of blood sugar control medications. If you experience serious allergic reactions such as angioedema, stop taking the medication immediately and inform your healthcare provider. Elderly patients should be cautious as this medication may increase dizziness or drowsiness, raising the risk of falls. Blurred vision or changes in eyesight may occur, and if these symptoms develop, consult with a healthcare professional. If this medication is suddenly discontinued, withdrawal symptoms like insomnia, headache, and anxiety may occur, so it should be gradually reduced as directed by a healthcare provider. Patients with a history of drug abuse should be monitored closely due to the potential for abuse. Patients with renal impairment may require dose adjustments. Patients with heart disease should be cautious as this medication may present symptoms of congestive heart failure. Caution should be taken when using this medication with opioid analgesics as it may enhance central nervous system depressant effects, leading to respiratory difficulties. In early pregnancy, there may be a risk of fetal malformations, so women who are pregnant or planning to become pregnant should discuss this with their healthcare provider. Dizziness and drowsiness are common, so driving or operating dangerous machinery should be avoided until these symptoms completely resolve. Severe skin reactions may occur, and if symptoms such as skin rash, fever, or mucosal damage appear, stop taking the medication immediately and visit a hospital. This medication is not recommended for use in children or adolescents under 19 years of age, as safety and efficacy have not been established. In the case of overdose, symptoms such as confusion, drowsiness, and depression may arise, and treatment such as hemodialysis may be necessary. Keep this medication out of reach of children and do not transfer it to other containers.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in mouth/eye mucosa, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities accompanied by coughing and fever, yellowing of skin or eyes (jaundice), severe malaise, sudden and severe headache, thunderclap headache, seizure, confusion of consciousness, visual disturbances, paralysis, urination

Mild side effects

• Dizziness
• drowsiness
• headache
• balance disorders
• lightheadedness
• swelling
• peripheral edema
• generalized edema
• chest pain
• fatigue

This medication is sensitive to air and moisture, so it should be stored in a tightly closed container. The best storage temperature is at room temperature, between 1°C and 30°C.

Appearance

Light yellow, oval-shaped, film-coated extended-release tablet

Package unit

30 tablets (6 tablets/PTP x 5)